PetLab Co.’s ProBright Advanced Dental Powder has earned top marks in a recent ranking of dog dental care products by Expert ...

Zoetis enjoys enviable financial flexibility, even as leverage ticked up in 2015 to finance the purchase of Pharmaq and Abbott's animal health business. With long-term debt at roughly $6.6 billion at ...

Shares in Zoetis (NYSE:ZTS) edged higher in premarket US trading on Monday after the drugmaker reported ...

Zoetis raised its annual profit and revenue forecasts on Monday on strong demand for its medicines and vaccines for animals.

Various veterinary businesses and organizations recently announced new promotions and appointments. The following individuals ...

A push from the Competition Bureau would see the distribution of pet medications expanded beyond veterinarian offices in a ...

The company has gained significant attention in the biotechnology sector due to its promising product pipeline and strong performance of its lead drug, Ayvakit. This analysis examines Blueprint ...

Blueprint Medicines has demonstrated robust financial performance, particularly with its flagship product, Ayvakit. In the second quarter of 2024, the company reported total revenues of $138.2 ...